Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jonathan Finn Insider Profile
4 Followers
Jonathan Finn, Ten Percent Owner at Cibus, holds 25.00K shares in Atossa Therapeutics (Ticker: ATOS), holds 1.52M shares in Cibus (Ticker: CBUS). Most recently, Jonathan Finn Bought ― shares of Atossa Therapeutics on Apr 11, 2024 for an estimated value of 44.25K.
Jonathan Finn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jonathan Finn holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jonathan Finn
Jonathan Finn's Trading History
Cibus
Jun 14, 2023
Ten Percent Owner
Uninformative Buy
―
$6.64M
Atossa Therapeutics
Apr 11, 2024
Director
Informative Buy
44.25K
$29.75K
List of latest transactions for each holding click on a transaction to see Jonathan Finn's performance on stock
You May Also Like
Jonathan Finn insider profile FAQ
What is the percentage of profitable transactions made by Jonathan Finn?
The percentage of profitable transactions made by Jonathan Finn is ―.
What is the average return per transaction made by Jonathan Finn?
The average return per transaction made by Jonathan Finn is ―.
What stocks does Jonathan Finn hold?
Jonathan Finn holds: CBUS, ATOS stocks.
What was Jonathan Finn’s latest transaction?
Jonathan Finn latest transaction was an Informative Buy of $44.25K.
What was Jonathan Finn's most profitable transaction?
Jonathan Finn’s most profitable transaction was an Informative Buy of ATOS stock on April 11, 2024. The return on the trade was -15.20%.
What is Jonathan Finn's role in Cibus?
Jonathan Finn's role in Cibus is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.